Skip to main content
main-content

Spondyloarthropathies

Feature content

21-02-2019 | Psoriatic arthritis | Feature | Article

The role of JAK inhibitors in the treatment of PsA

Dafna Gladman speaks to medwireNews about the trial data supporting the use of Janus kinase inhibitors in patients with psoriatic arthritis, and discusses the impact these agents may have.

21-02-2019 | Spondyloarthropathies | Feature | Article

Trials of JAK inhibitors in spondyloarthritis: A round-up

medwireNews rounds up the completed and ongoing clinical trials investigating JAK inhibitors in patients with spondyloarthritis.

11-01-2019 | Psoriatic arthritis | Editorial | Article

Screening psoriasis patients for development of psoriatic arthritis

Vinod Chandran discusses recent developments in screening tools for identifying patients with psoriatic arthritis, and those who are at high risk for developing this disease.

19-12-2018 | Diagnosis and screening | Podcast | Audio

The importance of early diagnosis and treatment of inflammatory arthritis

In this Medicine Matters rheumatology podcast, we talk to President-Elect of EULAR Professor Iain McInnes, about the importance of early diagnosis and treatment of rheumatic diseases.

18-12-2018 | Psoriatic arthritis | Feature | Article

Recognizing and managing cardiovascular risk in PsA patients

medwireNews speaks to Lihi Eder about why patients with psoriatic arthritis have elevated cardiovascular risk, and what can be done to mitigate it.

14-11-2018 | Infection | Editorial | Article

Minimizing infection risk with biologic therapy

While the development of biologics has revolutionized treatment of rheumatic diseases, these agents can lead to immunosuppression and increased infection risk. Eoin Feeney discusses the role of screening and treatment for latent infection prior to therapy, vaccination timing, and travel risks in patients taking these medications.

18-10-2018 | Microbiome | Editorial | Article

Why every rheumatologist should understand the microbiome

James Rosenbaum and Mark Asquith discuss how the microbiome interacts with the immune system, how this may induce inflammation, and how the microbiome could be used as a therapeutic target for rheumatic diseases.

10-10-2018 | Mental health | Editorial | Article

Why depression and anxiety matter in patients with inflammatory arthritis

Advisory Board member Susan Bartlett discusses the prevalence of mental health comorbidities in patients with inflammatory arthritis, and their impact on disease symptoms and quality of life.

07-09-2018 | Treatment | Feature | Article

At a glance: Common scores used in rheumatology

A quick-reference guide to the scores that are commonly used in clinical trials and daily rheumatology practice.

20-08-2018 | Psoriatic arthritis | Feature | Article

At a glance: Data supporting the approval of ixekizumab for PsA

A quick-reference guide to the clinical trial data supporting the approval of ixekizumab for the treatment of psoriatic arthritis.

20-08-2018 | Psoriatic arthritis | Feature | Article

Into the clinic: Ixekizumab for the treatment of PsA

medwireNews summarizes the key data supporting the approval of ixekizumab for the treatment of psoriatic arthritis, and discusses its place in the treatment landscape with Philip Mease and Laura Coates.

06-04-2018 | Spondyloarthropathies | Feature | Article

At a glance: Trials of tofacitinib in spondyloarthritis

A quick-reference guide to the published and ongoing clinical trials of tofacitinib for the treatment of spondyloarthritis.

19-12-2017 | Medications | Editorial | Article

Managing antirheumatic medication in patients undergoing elective arthroplasty

Editorial Board member Oliver FitzGerald reviews the recent guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty.

19-12-2015 | Psoriatic arthritis | Patient and physician’s perspective | Article

Living with psoriatic arthritis: A patient’s and physician’s perspective

This article, co-authored by a psoriatic arthritis (PsA) patient and a physician who regularly encounters and treats PsA patients, discusses the patient’s experience of the disease from diagnosis to living with the disease day-to-day.

Simmons A & Fleischmann R. Rheumatol Ther 2016;3:1–4. doi:10.1007/s40744-015-0024-9

image credits